The Series B round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures, Andreessen Horowitz (a16z), F-Prime, Maverick Ventures and JAZZ Venture Partners. The post Zus Health Raises $33M to Make Healthcare More Connected appeared first on MedCity News.

[Sponsored] ARPA-H portfolio companies in the Innovation Showcase included biosensor and wearable startups to monitor vital signs and to obtain patient data previously only available through blood tests. The post Biosensors and Wearables Among MedTech Showcased at INVEST Digital Health appeared first on MedCity News.

Windward Bio’s next-generation antibody drugs for immunology caught the interest of Sanofi, which bought shares in a private placement alongside the biotech’s IPO. Windward’s lead drug candidate addresses the same target as a blockbuster asthma drug from partners Amgen and AstraZeneca. The post Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs appeared first on MedCity News.

[Sponsored] Jason Tibbels, MD, Lantern Chief Medical Officer, described the company’s approach to making care more affordable without undermining quality or health outcomes in an interview with MedCity News Editor-in-Chief Arundhati Parmar at INVEST Digital Health. The post What’s Missing from Healthcare Quality Conversations? appeared first on MedCity News.

In an industry characterized by intense competition for specialized and high-level talent and complex compensation structures, leaders must treat pay transparency not merely as a compliance requirement, but as a strategic priority requiring strong internal alignment across an evolving global landscape. The post Pay Transparency in Life Sciences: Staying Ahead of Emerging Regulatory Complexity appeared first on MedCity News.

When governments fall short on public health, hospitals inherit the fallout. Those with the strongest brands are best positioned to withstand it. The post How Politics Became Every Hospital’s Brand Risk appeared first on MedCity News.

The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care. The post 62 Organizations Call on Congress to Advance 4 Medicare Reforms appeared first on MedCity News.

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal. The post Pfizer Deal With Blackstone Secures Up to $1.5B to Bankroll GLP-1 Drug Trials appeared first on MedCity News.

Healthcare systems are investing in AI to streamline workflows and save money, but a new study in the New England Journal of Medicine shows that AI-generated care plans might actually cost far more than those ordered by physicians. . The post Is AI Really Saving Hospitals Money? A New Study Raises Questions About the Cost of AI-Driven Care appeared first on MedCity News.

[Sponsored] Join us on December 9 at 1 p.m. ET for an Inovalon-sponsored webinar, where panelists will discuss why hospitals and post-acute care facilities continue to struggle with staffing shortages and turnover. They will also share practical ways to keep employees engaged, reduce burnout, and build more stable care teams. The post Sustaining Effective Care Teams During Staff Shortages  appeared first on MedCity News.

A large health system absorbs an appeal as routine. For a small agency with a few office staff, every hour chasing a physician signature or a face-to-face note is an hour not spent on patients. The post When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules appeared first on MedCity News.

Users are, rightfully, upset that the devices they bought are not delivering the results they were promised. But is that indignation pointed at the right flaw? The post Beyond Metrics: How to Repair Our Relationship With Wearables appeared first on MedCity News.

Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals. The post Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy appeared first on MedCity News.

Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide. The post Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans appeared first on MedCity News.

Democrats’ huge wins last week might mean big changes coming to healthcare across the country, especially in states which flipped blue. How might the shift in power affect affordability, access, and coverage? The post Democrats’ Midterm Wins Could Reshape Healthcare Access for Underserved Americans appeared first on MedCity News.